http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101115300-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-186 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 |
| filingDate | 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101115300-B1 |
| titleOfInvention | Hepatitis C virus-mediated liver disease prevention and treatment containing anti-NS5A antibody |
| abstract | The present invention relates to an agent for preventing and treating liver disease, and more particularly, to an agent for preventing and treating hepatitis C virus mediated liver disease, including an antibody against NS5A protein.n n n n HCV, NS5A, Monoclonal Antibody, hVAP-B, TRAF2 |
| priorityDate | 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 668.